EA Series Trust - MRBL Enhanced Equity ETF EBIT

EA Series Trust - MRBL Enhanced Equity ETF (EDGE) currently reports a EBIT of $-8.2B as of June 2026. That compares with $-10B in the prior-year period — up 20.0% year over year. That is below the Healthcare sector average of $22B. Use the charts on this page to explore EA Series Trust - MRBL Enhanced Equity ETF's EBIT history and peer comparisons.

EA Series Trust - MRBL Enhanced Equity ETF's EBIT increased from $-10B to $-8.2B — a 20.0% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

EA Series Trust - MRBL Enhanced Equity ETF's EBIT of $-8.2B is lower than the Healthcare sector average of $22B. That is roughly 136.6% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

EA Series Trust - MRBL Enhanced Equity ETF reported $-8.2B in EBIT as of June 2026. That compares with $-10B in the prior-year period — up 20.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $-8.2B, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $22B. From there, open related valuation or income-statement pages for EA Series Trust - MRBL Enhanced Equity ETF, and consider following EDGE for alerts when major investors trade the stock.